Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort

Study Overview
=================
Brief Summary
-----------------
AMI Survivors who participated in the project Construction and key technology research of the whole myocardial protection system for acute myocardial infarction (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.

Official Title
-----------------
Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort - a Prospective, Multicenter Study

Conditions
-----------------
Acute Myocardial Infarction, Adverse Event

Intervention / Treatment
-----------------
* Other: Treatment Strategies


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: AMI survivors who participated in the project Construction and key technology research of the whole myocardial protection system for acute myocardial infarction and completed the 1-year visit. Telephone to obtain informed consent from the subjects/family members of the subjects. Exclusion Criteria: Not available

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| optimized group<br>the patients received at least one optimized treatment | Other: Treatment Strategies<br>* AMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion<br>|
| un-optimized group<br>the patients didn't receive optimized treatment | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of MACCE | the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients | 5 years after discharge | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Differences of MACCE between the optimized group and the non-optimized group | Differences of the MACCE between the optimized group and the non-optimized group | 5 years after discharge | 
| Differences of the MACCE between OCT-guided group and the coronary angiography -guided group | Differences of the MACCE between OCT-guided group and the coronary angiography -guided group | 5 years after discharge | 
| Differences of MACCE between defer PCI group and direct PCI group | Differences of MACCE between defer PCI group and direct PCI group | 3 and 5 years after discharge | 
| Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group | Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group | 5 years after discharge | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Acute myocardial infarction, Major adverse cardiac and cerebrovascular event, Optimized treatment